Document:

Exhibit 10.5
                          World Waste of Anaheim, Inc.

                            Taormina Industries, LLC.

                             Waste Recycle Agreement

         This Waste Recycle Agreement (hereinafter "Agreement"),  dated June 27,
2003 (the "Effective Date") is made by and between World Waste of Anaheim, Inc.,
a California  Corporation,  (hereinafter  "WWA") having its principal offices at
5567 Calumet Avenue, La Jolla, California 92037 and Taormina Industries,  L.L.C.
(hereinafter  "TI" as further defined below herein) a Delaware limited liability
company having it's  principal  place of business at 1131 North Blue Gum Street,
Anaheim, California 92806.

A.       RECITALS

   1.    TI  operates  a large  volume  Material  Recovery  Facility  (MRF)  and
         Transfer  Station  in  Orange  County  and is a leading  processor  and
         recycler of the solid waste stream in Southern California.

   2.    As a solid waste collection  services  provider for a number of cities,
         TI is responsible  for  implementing  diversion  programs to reduce the
         amount of solid  waste from  landfill  disposal  in order to assist its
         public  agency  customers to meet the  diversion  goals and mandates of
         AB939.

   3.    TI currently employs many proprietary and commercially  available means
         to recover material from the waste stream in order to provide diversion
         for its customers who utilize the facility.

   4.    TI is continually exploring means to enhance recovery efforts,  provide
         additional  diversion for its existing  customers and provide diversion
         opportunity for future customers.

   5.    WWA is the exclusive  licensee of a process,  which recovers  materials
         from the waste stream beyond the recovery  levels of traditional  solid
         waste processing.

   6.    WWA has worked closely  with TI for several  years to develop  and test
         the viability of its exclusive licensed patented recovery process.

   7.    WWA is seeking a location for their first commercially  viable facility
         that can  receive,  process and  recover  material  from the  residuals
         stream of the MRF.

   8.    TI  desires  to  engage  WWA's services on the terms and conditions set
         forth herein.

   9.    WWA desires to process waste materials received from TI and is  willing
         to do so on the  terms and conditions set forth herein.

Confidential and Proprietary
Subject to Confidentiality Agreement
Prohibiting Disclosure

                                Exhibit 10.5 - 1
<PAGE>
   10.   It is TI's  intention to deliver the agreed upon average  tonnage as it
         is WWA's  intention  to receive and  process  the agreed upon  tonnage;
         however,  from time to time  circumstances may occur, such as holidays,
         which  could  briefly   interrupt  the  intended  even  flow  of  waste
         materials.  Both parties to this Agreement will make their best efforts
         to deliver and  receive  the agreed  upon  tonnage as it is in the best
         interest of both parties to do so.

   THEREFORE,  in  consideration  of  the  above  recitals  and  of  the  mutual
   promises and conditions in this agreement, it is agreed as follows:

B.       TERM OF CONTRACT

         The term of this  agreement  shall be ten (10) years,  with options for
three  additional  extensions  of five (5)  years  each,  exercisable  by mutual
agreement of the parties,  for a total  potential term of 25 years. TI may agree
to extend the term of this Agreement  pursuant to a written  notification of the
extension served on WWA pursuant to section K(11) of this Agreement.

C.       LEASE OF RECYCLING FACILITY

   1.    During  the  term of  this  Agreement  the  location  of the  recycling
         facility  shall be a structure on the TI property  located at 2740 East
         Coronado Street, Anaheim,  California,  or an equivalent and compatible
         building  approved in writing by both  parties.  TI agrees to cooperate
         with and assist WWA in obtaining  all required  land use  approvals and
         modifications of existing TI permits;  permits for modifications to the
         existing  buildings,   easements,  utility  services,  and  permits  to
         construct,  install equipment and operate the WWA facility on the above
         identified  TI property.  The costs of all permits,  authorizations  or
         approvals for the use of the TI facility,  including without limitation
         all capital and  maintenance  expenditures  associated  with making the
         site suitable for the  implementation  of the terms of this  Agreement,
         shall be the sole expense of WWA.

   2.    WWA and TI agree that WWA will lease the  proposed  building for a term
         of ten (10) years at the rental rate of $.53 per square foot ("the Base
         Rent"), adjusted annually on a calendar year basis on January 1 of each
         year using 100% of the "Los  Angeles-Anaheim-Riverside  CPI Index,  All
         Urban Consumers",  as determined in the month of November preceding the
         January  anniversary  date for  adjustment of the Base Rent.  WWA shall
         have  the  option  to renew  the  lease  to  coincide  with the TERM OF
         CONTRACT  as  delineated  in section B of this  Agreement.  The parties
         agree that the square  footage of the  facility  under  lease  shall be
         approximately  30,000  square  feet,  with an  initial  Base  Rent of a
         minimum of $15,900.00 per month (30,000 X $.53/ft.). In addition to the
         Base Rent,  the  parties  agree that WWA shall be  responsible  for the
         payment  of  any  additional  or  supplemental  real  estate  taxes  or
         incremental  operating costs directly associated with the WWA operation
         resulting  from  the  leased   facility.   Additionally  WWA  shall  be
         responsible  for monthly  service  costs of all  utilities  serving the
         leased facility.  At TI's option,  the additional taxes and incremental

Confidential and Proprietary
Subject to Confidentiality Agreement
Prohibiting Disclosure

                                Exhibit 10.5 - `2
<PAGE>
         operating  expenses  may be assessed on a monthly  basis as  additional
         rent in addition to the Base Rent, or may be separately invoiced to WWA
         on an annual or more frequent basis.

   3.    TI agrees to defer  the Base  Rent for the first  twelve  months of the
         lease term as an  accommodation to WWA. This first year's deferred Base
         Rent shall be paid in 48 equal  interest-free  payments spread over the
         next 48 months (4 years) of the 10 year term of the lease  beginning in
         the 13th month of the lease term.

   4.    TI  agrees  to assist to make any  necessary  changes  to the  existing
         building  for  accommodation  of the  addition  of the  WWA  processing
         facility,  so long as such  changes do not impair or impede the conduct
         of TI's other  business  operations at the TI site.  WWA agrees that TI
         has final  approval  of any and all  building  modifications,  material
         flows and the overall processing which takes place on TI property.

   5.    TI and  WWA  agree  that  they  shall  enter  into a  standard  form of
         commercial  lease  agreement  with the  provisions  in this  section  C
         included,  in substantially  the same form as set forth in the attached
         Exhibit A and  incorporated  by  reference  as  though  fully set forth
         herein.

D.       TI'S DUTIES AND OBLIGATIONS:

   1.    TI  shall  provide  to WWA a  mutually  agreed  upon  mix  of  Residual
         Municipal  Solid Waste  ("RMSW") on a 24 hour,  6 day per week basis as
         requested by WWA. For purposes of this  Agreement,  RMSW shall mean the
         MSW remaining after TI's sorting operation.  TI will endeavor to remove
         from MSW large  bulky  items such as pallets,  engine  blocks,  bicycle
         frames, tires, and similar types of bulky materials,  which will not be
         processed by WWA. RMSW may also include mixes of non-sorted commercial,
         apartment  and household  waste as mutually  agreed to by WWA and TI in
         writing.

   2.    TI will  deliver  an  average  of 3,500  tons  per week to the  on-site
         facility  leased by WWA pursuant to this  Agreement at a schedule to be
         mutually agreed upon in writing by WWA and TI.

   3.    TI shall deliver up to an  additional  14,000 tons per week on average,
         adjusted for holidays,  of RMSW to WWA's proposed new off-site facility
         upon  WWA's  written  notification  to TI.  Delivery  by TI to the  new
         off-site  facility is  contingent  upon TI's  approval of the  proposed
         facility,  and the facility being located within a mutually agreed upon
         location,  and distance from TI's Anaheim facility,  as determined in a
         written modification to this Agreement.

   4.    TI can  deliver  loads 24 hours per day, 6 or 7 days per week,  at TI's
         option, excluding major holidays.

   5.    The  composition of the RMSW may be adjusted as mutually agreed upon in
         writing by WWA and TI.

Confidential and Proprietary
Subject to Confidentiality Agreement
Prohibiting Disclosure

                                Exhibit 10.5 - 3
<PAGE>
   6.    TI will haul away all  unprocessible  wastes and RMSW process residuals
         (hereinafter "WWA Residual") from the WWA facility on a mutually agreed
         upon commercially acceptable schedule.

   7.    TI will have final  design  review in  accordance  with  paragraph C. 4
         above on how vehicles  enter and exit the facility and how WWA Residual
         is picked up/loaded, as well as the exterior appearance of the facility
         (if on TI's property) along with all regulatory compliance issues.

   8.    TI has the option in its sole  discretion to remove any waste  material
         that is  deemed  by TI to be a  potential  threat  to  public or worker
         health and safety,  or the presence of which would cause or threaten to
         cause TI to be in  non-compliance  with any  term or  condition  of any
         permit or entitlement for operation of TI's facility.

   9.    Each and every  obligation of TI as set forth herein is subject to TI's
         ability to maintain  compliance with its permits and  entitlements  for
         operation  of the TI  facility in  Anaheim.  Nothing in this  Agreement
         shall be construed to require or result in TI's non-compliance with its
         permits  and  entitlements,  or to  place  it in  breach  of any law or
         regulation governing operation of the TI facility.

   10.   "TI" shall mean TI, its parents,  other subsidiaries of TI's parent and
         affiliates.

   11.   TI agrees that it will  indemnify,  defend and hold  harmless  WWA, its
         directors,  officers, employees, agents and consultants from any claims
         or causes of  action,  including  without  limitation  any  claims  for
         personal  injury,  property  damage  or  civil  or  criminal  fines  or
         penalties arising from TI's operations pursuant to this Agreement.

E.       WWA DUTIES AND OBLIGATIONS

   1.    WWA shall comply with all laws and regulations,  which apply to the WWA
         process,  and the leased facility  described  above. WWA agrees that it
         will indemnify,  defend and hold harmless TI, its directors,  officers,
         employees,  agents and consultants from any claims or causes of action,
         including without  limitation any claims for personal injury,  property
         damage or civil or  criminal  fines or  penalties  arising  from  WWA's
         operations pursuant to this Agreement.

   2.    WWA shall obtain and  maintain  throughout  the term of this  Agreement
         (including  any  extensions  thereof),  all  permits  and  entitlements
         required  by law for  operation  of the leased  facility as well as the
         proposed new off-site  facility.  If, as a result of a future change in
         law or a change in the  interpretation of existing law as a result of a
         judicial order from a federal or state court of competent jurisdiction,
         the  recovered  materials  do not  qualify  for  full  and  unqualified
         diversion credits under California law, then TI shall have the right to
         reopen this Agreement and  renegotiate the per ton tip fee in effect at
         that time.

Confidential and Proprietary
Subject to Confidentiality Agreement
Prohibiting Disclosure

                                Exhibit 10.5 - 4
<PAGE>
   3.    Upon  expiration  or  termination  of the  lease,  WWA  shall,  at TI's
         election,  remove all equipment  and/or restore the leased  facility to
         leaseable condition less commercially acceptable wear and tear.

   4.    WWA  shall  obtain  and  maintain  authorization  from  the  California
         Integrated Waste Management Board ("CIWMB")  stating that operations in
         the leased facility and the proposed new off-site  facility  constitute
         material   recovery   operations   pursuant  to  California   laws  and
         regulations  governing solid waste and materials  recovery  facilities.
         WWA  represents  and warrants that no amendment to TI's existing  solid
         waste SWFP or a new solid waste facilities permit shall be required for
         operation of the leased facility.  WWA further  represents and warrants
         that it shall guarantee a WWA residual of no more than 40% by weight of
         TI waste delivered to and processed at the WWA facility.

   5.    WWA shall provide a written  report to TI annually,  in January of each
         year,  detailing the use and re-use of the recovered materials produced
         using RMSW from TI. WWA has  represented  that the initial  anticipated
         markets are pulp and LCM (loss  circulation  mud).  Upon  request,  WWA
         shall provide any necessary  documentation  to TI on the use of the WWA
         recovered material as may be required for TI to comply with regulations
         regarding  qualification for diversion or other obligations  imposed on
         TI by regulatory agencies regarding the use of recovered materials.

   6.    If TI determines  that WWA's  operations are not in compliance with any
         applicable  law  or  regulation  or  determines  that  WWA's  continued
         operation   would  place  or  threaten  to  place  TI's  operations  in
         non-compliance  with its  permits  and  approvals,  then TI may suspend
         delivery of RMSW to WWA until such time as TI  determines  that WWA has
         fully remedied the non-compliance or threat of non-compliance.

   7.    As used herein, the term "law" includes, without limitation,  statutes,
         regulations,  administrative orders and decrees, judicial decisions and
         orders of courts of the State of California and the United States.

   8.    WWA's  facilities  to be  constructed  and  operated  pursuant  to this
         Agreement  shall  be for  the  exclusive  use of TI and  its  affiliate
         entities,  and no other person,  firm or entity shall have any right or
         entitlement  to  utilize  the  WWA  facilities   without  TI's  written
         approval.  WWA agrees  that it will accept and process all of the waste
         materials  that TI is  obligated  to  deliver  under  the terms of this
         Agreement.

F.       COMPENSATION

   1.    WWA will sell its "Standard"  recyclables  (steel,  aluminum,  plastic)
         through TI under the  conditions  outlined  below.  TI will pay WWA ten
         percent (10.0)% less than TI's average  monthly market price.  The term
         "average  monthly  market price" means the average  monthly price TI is
         paid  for  each of the  standard  recycled  materials  in the  recycled
         materials  market  within the  geographic  territory of Orange  County,
         California.

Confidential and Proprietary
Subject to Confidentiality Agreement
Prohibiting Disclosure

                                Exhibit 10.5 - 5
<PAGE>
   2.    Pick Up Schedule:  "On  Call"--WWA  will call TI to pick up recyclables
         from  the  WWA  facility  and  deliver  them to its  Material  Recovery
         Facility.  A weight ticket will be generated to record the incoming net
         material  weight - Gross  less  Tare/Empty  weight.  The  load  will be
         inspected to the  specifications of the commodity it is receiving.  All
         required  commodity  specifications  will be agreed  upon  prior to the
         delivery of any loads. TI shall achieve  pick-ups within eight hours of
         notification by WWA.

   3.    TI agrees to pay WWA an  initial  base tip fee of $30.00 per ton of Net
         Processed  Waste.  Net  Processed  Waste  equals  the  total  RMSW tons
         delivered  to the WWA  facility  less the total  Residual/non-processed
         tons removed by TI for handling  and disposal by TI.  Payments  will be
         made monthly on total tonnage of Net Processed  Waste. The initial base
         tip fee of $30.00 per ton shall be  increased or decreased as necessary
         for the  remainder of the Term such that the tip fee shall  increase or
         decrease on a dollar for dollar basis in accordance  with any change to
         the  Orange  County  landfill  disposal  fees from a base year of 2003,
         which is $22.00 per ton.

   4.    Delivery Procedures/Payment  Calculation: All incoming RMSW to WWA will
         be  weighed  on one of TI's  scales or  another  certified  scale and a
         weight ticket generated. The Gross and Tare/Empty,  and Net Weight will
         be shown in  addition  to the date and truck #. A copy of the  incoming
         weight ticket will be given to WWA and one kept at the CVT  Scalehouse.
         All outgoing  residual  waste will be handled in the same  manner.  All
         weight  tickets need to be clearly  marked as Incoming or Outgoing.  At
         the end of the month,  the total  outgoing  residual net weight will be
         subtracted from the Incoming RMSW weight to determine the Net Processed
         weight.

G.       WWA's OWNERSHIP OF INTANGIBLES

         All processes,  inventions, patents, copyrights,  trademarks, and other
intangible  rights that may be conceived  or  developed by WWA,  either alone or
with  others,  during the term of this  Agreement,  whether or not  conceived or
developed  during WWA's working hours,  and with respect to which the equipment,
supplies,  facilities,  or trade  secret  information  of WWA was used,  or that
relate at the time of  conception  or reduction to practice of the  invention to
the  business  of WWA or to  actual or  demonstrably  anticipated  research  and
development,  or that  result from any work  performed  by WWA shall be the sole
property of WWA.

H.       CONFIDENTIALITY OF PROPRIETARY INFORMATION

         TI  and  WWA  agree  that  this  Agreement  and  the  contents  thereof
constitute  valuable trade secret information that shall not be disclosed to any
third party without the prior written consent of the Parties  hereto.  TI agrees
that neither it nor any agent of TI will  disclose any  Proprietary  Information
(as hereinafter defined) to any individual or entity at any time during the term
of this Agreement, except as is necessary and appropriate in the ordinary course
of performing  duties for WWA during the term of this Agreement,  or unless such

Confidential and Proprietary
Subject to Confidentiality Agreement
Prohibiting Disclosure

                                Exhibit 10.5 - 6
<PAGE>
disclosure  is  required  by law.  For  purposes  of this  Agreement,  the  term
Proprietary  Information shall mean any information that was developed by or was
assigned to WWA, and which has commercial  value in WWA's business.  Proprietary
Information  includes,   but  is  not  limited  to,  trade  secrets,   financial
information,  customer  lists  and  information,  marketing  plans,  strategies,
business forecasts,  computer programs, source code, product plans, research and
development information, testing methods and results, inventions,  improvements,
formulas,  processes,  techniques,  designs, know-how and data. TI and WWA agree
that violation of this Section H will cause  irreparable  harm to TI and/or WWA,
as the case may be,  therefore  in addition to any and all other legal  remedies
available to it, WWA or TI shall be entitled to equitable and injunctive relief.

I.       NON-COMPETITION  AND  RIGHT OF FIRST REFUSAL FOR CO-OWNERSHIP OF FUTURE
         PROJECTS

   1.    During the term of this Agreement, WWA will not directly or indirectly,
         compete with the  facilities  or business  opportunities  of TI for any
         solid waste or recyclable  materials,  including receipt of MSW or RMSW
         within TI's market  areas.  WWA agrees that it will not take any action
         that would impair or impede the ability of the 500 TPD and the off-site
         facility to meet the performance requirements of those facilities.

   2.    (a)  TI  shall  have  a  first  right  of  refusal   with   respect  to
         participation  with WWA as an equity partner in any Project proposed by
         WWA within TI's market areas of (i) Orange County,  Los Angeles County,
         San Bernardino County, Riverside County, and (ii) Alameda County, Santa
         Clara County, Contra Costa County, Solano County, Marin County, and San
         Joaquin County.  Equity  participation shall mean that TI shall have an
         equity  share of  fifty-one  percent  (51%) or greater  in any  Project
         proposed by WWA, in exchange for contributing  fifty-one  percent (51%)
         or greater of the capital funding  required for the Project.  "Project"
         as used herein, shall mean each separate business opportunity in the TI
         market area(s) set forth in this  paragraph  2.(a) that WWA proposes to
         engage in,  which  Projects  shall be  capitalized  as  separate  legal
         entities on a Project by Project basis.  As used in (a) herein,  "first
         right of  refusal"  shall  mean that TI shall  have the  right,  at its
         election, to participate in a Project within the market areas set forth
         in (i) and (ii) above, after WWA has presented a bona fide proposal for
         a Project to TI. Once a bona fide  Project  proposal is presented to TI
         in  writing,  TI  shall  then  have a period  of  ninety  (90)  days to
         determine if it will exercise its right and elect to  participate as an
         equity partner in any such Project.

         (b) TI will have a first right of refusal to  participate  with WWA, or
         utilize WWA in materials processing,  in any governmental  solicitation
         for proposals (i.e., Requests For Proposals, Invitation for Bids, etc.)
         within the State of California. WWA agrees that it will consult with TI
         at least forty five (45) days prior to WWA either (i) responding to any
         RFP, IFB or similar process,  or (ii) WWA proposing to joint venture or
         otherwise  collaborate with any competitor of TI in connection with any
         such  RFP or IFB  response.  As used in (b)  herein,  "first  right  of

Confidential and Proprietary
Subject to Confidentiality Agreement
Prohibiting Disclosure

                                Exhibit 10.5 - 7
<PAGE>
         refusal" shall mean that TI shall have the right,  at its election,  to
         participate with WWA on a joint  cooperative basis in making a proposal
         in response to any governmental solicitation for proposals.

         (c) As used  herein,  the term  "bona  fide  proposal"  means  that all
         material terms and  conditions of a proposed  agreement have been fully
         and finally negotiated and memorialized in a draft written agreement as
         between WWA and a third party,  and  presented in writing to TI for its
         review.

   3.    During the period of this  agreement TI will not utilize any of the WWA
         processing   technology  in  its  operations  without  express  written
         permission from WWA.

J.       INSURANCE PROVISIONS.

         For  purposes of this  agreement  WWA and TI shall carry the  following
         types of insurance in at least the limits  (which may be a  combination
         of primary and excess coverage) specified below:

         Coverages                                  Minimum Limits of Liability
         ---------                                  ---------------------------
         Workers' Compensation                      Statutory

         Employer's Liability                       $1,000,000/occurrence

         Automobile Liability                       $2,000,000/occurrence

         Comprehensive General Liability,           $2,000,000/occurrence
         Including Bodily Injury, Property Damage   $2,000,000/general aggregate

         Excess Coverage                            $3,000,000/occurrence

                                                    $3,000,000/aggregate

         TI and WWA shall be named as an  additional  insured on all policies of
         insurance,  and WWA agrees to provide certificates of coverage from its
         carrier(s). The Comprehensive General Liability,  Excess and Automobile
         policies shall contain a waiver of subrogation against TI.

K.       GENERAL PROVISIONS

   1.    Governing  Law  and  Venue.  This  Agreement  will be  governed  by and
         construed in accordance with the laws of the State of California. Venue
         for any dispute arising out of or from this Agreement, whether in tort,
         contract or both,  shall be in a State court of competent  jurisdiction
         in Orange County,  California.  This Agreement  shall be subject to all
         applicable  laws and  regulations  concerning the subject matter of the
         Agreement.

Confidential and Proprietary
Subject to Confidentiality Agreement
Prohibiting Disclosure

                                Exhibit 10.5 - 8
<PAGE>
   2.    Assignment.  Neither  WWA or TI may  assign,  pledge  or  encumber  its
         interest  in this  Agreement  or any part  thereof  without  the  prior
         written  consent of the other Party.  The term  "Assignment"  shall not
         include any changes  (1), in corporate  structure or (2),  resulting in
         less than a 50 percent  (50%)  change in the  beneficial  ownership  of
         either Party.

   3.    Applicability.  This  Agreement,  unless  and  except  where  expressly
         limited, inures to the benefit of and shall be binding upon the Parties
         and their  successors  and  assigns as may be  authorized  pursuant  to
         paragraph 2 above.

   4.    No Waiver of  Breach.  The  failure to enforce  any  provision  of this
         Agreement will not be construed as a waiver of any such provision,  nor
         prevent a party  thereafter  from  enforcing the provision or any other
         provision  of this  Agreement.  The  rights  granted  the  parties  are
         cumulative,  and the  election of one will not  constitute  a waiver of
         such  party's  right to assert all other legal and  equitable  remedies
         available under the circumstances.

   5.    Severability.  The provisions of this  Agreement are severable,  and if
         any provision will be held to be invalid or otherwise unenforceable, in
         whole or in part,  the remainder of the  provisions  shall be construed
         and enforced so as to give effect to the  remaining  provisions  of the
         Agreement.

   6.    Entire  Agreement.  This Agreement  constitutes the entire agreement of
         the parties with respect to the subject matter of this  Agreement,  and
         supersedes all prior and contemporaneous  negotiations,  agreements and
         understanding between the parties, oral or written.

   7.    Modification,   Waivers,   Amendment.  No  modification,   termination,
         amendment or attempted waiver of this Agreement will be valid unless in
         writing, signed by both parties.

   8.    Fees and Expenses.  If any proceeding is brought for the enforcement or
         interpretation  of this Agreement,  or because of any alleged  dispute,
         breach,  default or misrepresentation in connection with any provisions
         of this Agreement, the prevailing party in any such proceeding shall be
         entitled to recover from the other party reasonable attorney's fees and
         other costs incurred in that proceeding  (including expert witness fees
         and costs),  in addition to any other relief to which such party may be
         entitled.

   9.    Duplicate  Counterparts.  This  Agreement  may be executed in duplicate
         counterparts,  each of which  shall be  deemed an  original;  provided,
         however,   such  counterparts   shall  together   constitute  only  one
         instrument.

Confidential and Proprietary
Subject to Confidentiality Agreement
Prohibiting Disclosure

                                Exhibit 10.5 - 9
<PAGE>
   10.   Drafting  Ambiguities.  Each  party  to  this  Agreement  has  had  the
         opportunity  to consult  with counsel  regarding  the  advisability  of
         signing this Agreement and the meaning of the terms herein.  Each party
         (and, if applicable, his or its counsel) have participated fully in the
         review and revision of this Agreement.  Any rule of construction to the
         effect that  ambiguities are to be resolved  against the drafting party
         shall not apply to interpreting this Agreement.

   11.   Notices.  Any notice to the parties  required or  permitted  under this
         Agreement  shall be given in writing by certified mail sent to the then
         principal place of business.

   12.   Force Majeure. "Force Majeure" shall mean any event or condition having
         a material and adverse effect on the rights,  duties and obligations of
         either party hereunder,  or on the Facility,  or on the lease,  design,
         construction,  equipping,  start-up, operation, ownership or possession
         of any or all of  them,  if such  event  or  condition  is  beyond  the
         reasonable  control,  and not the result of willful or negligent action
         or omission or a lack of reasonable  diligence,  of the party asserting
         the Force  Majeure;  provided that the  contesting in good faith of any
         event or condition constituting a change in law shall not constitute or
         be construed as a willful or negligent  action or a lack of  reasonable
         diligence  of  such  party.  The  foregoing  provisions  shall  not  be
         construed  to require that either  party  observe a higher  standard of
         conduct  than  required  by the usual and  customary  standards  of the
         industry in question,  as a condition  to claiming  the  existence of a
         Force Majeure.  Such events or conditions may include, but shall not be
         limited  to,  circumstances  of the  following  kind:  an  act of  God,
         epidemic, landslide, lightning, hurricane, earthquake, fire, explosion,
         storm, flood or similar  occurrence,  an act of war, effects of nuclear
         radiation, blockade,  insurrection,  riot, civil disturbance or similar
         occurrences, strikes, lockouts, work slowdowns or stoppages, or similar
         labor difficulties  affecting either party hereunder,  or the operation
         of the  leased  Facility,  or  otherwise  affecting  or  impacting  the
         performances of either party's  contractors and suppliers;  a change in
         law.

Taormina Industries, LLC                    World Waste of Anaheim, Inc.

/s/ Thomas Vogt                             /s/ Steven L. Racoosin
-----------------------------               ------------------------------
Thomas Vogt, President                      Steven L. Racoosin, President

June 27, 2003                               June 27, 2003
-----------------------------               -------------------------------
Date                                        Date

         Executed by the parties as of the day and year first above written.
Confidential and Proprietary
Subject to Confidentiality Agreement
Prohibiting Disclosure

                                Exhibit 10.5 - 10Exhibit 10.6

                AMENDED AND RESTATED TECHNOLOGY LICENSE AGREEMENT

         This   Amended  and  Restated   Technology   License   Agreement   (the
"Agreement")  is made and  entered  into  June 21,  2004,  between  Bio-Products
International,  Inc. ("Bio-Products"),  a company incorporated under the laws of
the State of Alabama (the "Licensor"), and World Waste Technologies, Inc. (WWT),
a  company  incorporated  under  the  laws  of  the  State  of  California  (the
"Licensee")  (the Licensor and Licensee may  hereinafter be either  individually
referred to as the "Party" or collectively referred to as the "Parties").

                                    PREMISES:

         Whereas, Dr. Michael H. Eley ("Eley"), in his continuous capacity as an
employee of the University of Alabama in Huntsville  ("UAH"),  developed certain
proprietary  intellectual  property,  patented  processes,  and  patent  pending
processes  for the volume  reduction,  separation,  recovery,  and  recycling of
various components of waste materials,  including without limitation,  Municipal
Solid  Waste  ("MSW"),  which  technology  has been  reduced to U.S.  Patent No.
6,306,248  (the "U.S.  Patent")  and Patent  Cooperation  Treaty,  International
Application No. PCT/US01/50049 (the "PCT") (collectively, the "UAH Technology").
The UAH Technology  constitutes  the first of the two parts of the  "Technology"
(as defined  herein).  Eley is also a major  stockholder,  President  and CEO of
Bio-Products;

         Whereas,   pursuant  to  that  certain  Amended  and  Restated  License
Agreement, effective August 18, 2003, which supersedes and replaces the original
license agreement dated November 13, 1992, which was amended effective  November
5,  1997  and  amended  again  effective  August  31,  1999,   between  UAH  and
Bio-Products  (the "Amended and Restated UAH License") (a complete copy of which
is  attached  as Exhibit  A),  UAH  granted an  exclusive  worldwide  license to
Bio-Products  covering the UAH  Technology,  including the rights to make,  have
made, use, lease and sell certain products,  and to practice certain  processes,
and to license some or all of the rights  granted to others,  such  products and
processes being more specifically defined in the UAH License;

         Whereas,  Donald E. Malley  ("Malley")  developed  certain  proprietary
intellectual  property,  equipment  designs,  and process  operating  procedures
related  to the  UAH  Technology,  including  the  expertise  and  know-how  for
fabrication and continuous operation of a small waste reduction process plant at
a commercial  sanitary  landfill for a period of eighteen months  (collectively,
the  "Malley  Technology").  Malley  has  assigned  all  rights  to  the  Malley
Technology to  Bio-Products  (a complete copy of the Amended and Restated  Stock
Purchase  and  Assignment  Agreement  is  attached  as  Exhibit  B).  The Malley
Technology  constitutes  the  second  of the two parts of the  "Technology"  (as
defined  herein).  Malley  is  also  a  stockholder  and  a  Vice  President  of
Bio-Products;

         Whereas,  the original  Technology  License  Agreement,  dated June 21,
2002,  was  between   Bio-Products  and  World  Waste  Holdings,   Inc.  (WWHI),
incorporated under international law in Anguilla,  British West Indies, and WWHI
assigned the said Technology  License Agreement to World Waste of America,  Inc.
(WWA),  a  company  incorporated  under  the laws of the  State  of  California,
effective May 12, 2003 (a complete copy of which is attached as Exhibit C);

                                Exhibit 10.6 - 1
<PAGE>
         Whereas,  WWA  and all of its  assets,  including  the  June  21,  2002
Technology License Agreement with Bio-Products, was acquired by Waste Solutions,
Inc. (WSI), a California  corporation,  in a merger and  reorganization in which
WWA became a wholly owned  subsidiary  of WSI,  dated March 22, 2004 (a complete
copy of which is attached as Exhibit D);

         Whereas,   WSI  filed  a  Certificate   of  Amendment  of  Articles  of
Incorporation to the Secretary of State of the State of California  changing the
name of the  corporation  to World Waste  Technologies,  Inc. (WWT) on March 24,
2004 (a complete copy of which is attached as Exhibit E);

         Whereas,  Bio-Products  desires to enter into a license  agreement with
the  Licensee  to  provide  the  Technology  and  future  improvements  for  the
construction  and operation of commercial scale municipal solid waste processing
and recycling facilities subject to the terms and conditions set forth herein;

         Whereas, the Licensee either has the financial resources, or has agreed
to use their best  efforts to secure the  financial  resources,  for the design,
engineering, and fabrication of processing equipment and facilities, acquisition
and  permitting  of  construction  sites,   purchase  of  processing  equipment,
construction and operation of processing facilities, and marketing and promotion
of commercial facilities that are compatible with the Technology;

         Whereas,  the Licensee  desires to enter into a license  agreement with
Bio-Products  to use the Technology  for commercial  purposes upon the terms and
conditions hereinafter set forth;

         Whereas,  the Parties wish to amend and restate the original Technology
License Agreement, dated June 21, 2002, between the Parties as herein set forth,
which date shall remain the effective date of this Agreement; and

         Now,  therefore,  in  consideration  of the  premises  and  the  mutual
covenants contained herein, the Parties hereto agree as follows:

                             ARTICLE I - DEFINITIONS
                             -----------------------
         For purposes of this  Agreement,  the following words and phrases shall
have the following meanings:

         1.1 "Technology" shall mean the inventions, technology, and proprietary
intellectual property and information  developed by Bio-Products,  Eley, Malley,
and UAH  created  or  discovered  prior to or after the  effective  date of this
Agreement,  including,  but  not  limited  to,  inventions,  processes,  process
operating  procedures  and  discoveries,  patents,  patent  applications,  trade
secrets, developments, facility designs, equipment designs, works of authorship,
formulas, software programs, techniques, information, expertise, know-how, data,
research,  mask works, all  intellectual  and industrial  property rights of any
sort, all rights of integrity,  disclosure  and  withdrawal,  copyrights,  trade
names  and  trademarks,   which  are  related  to  the  recycling,   processing,
collection,  storage, disposal, treatment,  utilization or reduction of waste or
waste  components or the  conversion  of cellulosic  materials to fuels or other
materials or other use of cellulosic  materials for the  production of energy or
otherwise.  Technology  includes  without  limitation,  the UAH Technology,  the
Malley Technology,  United States Patent Number 6,306,248 and Patent Cooperation
Treaty International Application Number PCT/US01/50049.

                                Exhibit 10.6 - 2
<PAGE>
         1.2  "Third   Party"  shall  mean  any  person  or  entity  other  than
Bio-Products, Eley, Malley, UAH, the Licensee and sub-licensees of the Licensee.

         1.3  "Operating  Day"  shall  mean  a day in  which  the  facility  (i)
processes waste equal to or in excess of the facility's  daily design  capacity;
or (ii)  processes  all of the waste  brought to the facility for  processing on
such  day;  or (iii)  processes  as much  waste  as  allowed  by any  downstream
limitations,  such as but not  limited  to, any  limitations  on the  downstream
processing or disposal of the cellulosic product.

                          ARTICLE II - GRANT OF LICENSE
                          -----------------------------
         2.1 Subject to the terms and conditions of this Agreement, Bio-Products
hereby  grants a license to the Licensee to utilize the  Technology to construct
and operate  commercial  scale  municipal  solid waste  processing and recycling
facilities in the U.S.A.

         (a) The license  granted by  Bio-Products  to the  Licensee  under this
             Agreement shall be exclusive in all of the States, territories, and
             possessions of the USA with the following exceptions: (i) the State
             of Arkansas shall remain exclusively licensed to Bio-Products; (ii)
             Bio-Products  shall  retain  the  right to  construct  and  operate
             additional facilities utilizing the Technology in one or all of the
             States of  Alabama,  Tennessee,  Georgia,  and/or  South  Carolina,
             providing  the total number of  facilities in these States does not
             exceed four (4); and (iii) for applications in which the cellulosic
             product  of  waste,   including   Municipal  Solid  Waste  ("MSW"),
             processed  utilizing  the  Technology  is either used directly as a
             fuel source or converted into an end product for energy production.
             The above notwithstanding, upon written requests from the Licensee,
             (i)  Bio-Products  shall grant  site-specific  sub-licenses  to the
             Licensee  to  construct  and  operate   facilities   utilizing  the
             Technology in the State of Arkansas, (ii) Bio-Products shall invite
             the  Licensee  to  participate  in  any or  all  of  its  four  (4)
             facilities outside of the State of Arkansas, and (iii) Bio-Products
             shall  grant   site-specific   sub-licenses  to  the  Licensee  for
             applications  in which the cellulosic  product of waste,  including
             MSW, processed  utilizing the Technology is either used directly as
             a  fuel  source  or  converted  into  an  end  product  for  energy
             production.

         (b) For  each  facility  to be  constructed  and  operated  under  this
             Agreement by the Licensee,  a proposal on the economic  feasibility
             of the facility shall be prepared and submitted to Bio-Products for
             review and  comment.  Bio-Products  shall  submit its  comments  in
             writing to the  Licensee in a timely  manner,  not to exceed  sixty
             (60) days.  The Licensee  shall,  at its  discretion,  then grant a
             site-specific sub-license to a USA entity (the "Sub-Licensee") that
             shall own and/or operate the facility.  Such sub-license  agreement
             shall be subject to the approval of  Bio-Products,  which  approval
             shall not be unreasonably withheld.

         (c) As stated in Paragraph 2.1(a),  Bio-Products shall retain the right
             to construct  and operate up to four (4)  facilities  utilizing the
             Technology in the States of Alabama, Tennessee,  Georgia, and South

                                Exhibit 10.6 - 3
<PAGE>
             Carolina.  Bio-Products  shall prepare and submit a proposal on the
             economic  feasibility  of each  facility to the Licensee for review
             and comment,  and the Licensee shall submit its comments in writing
             to Bio-Products in a timely manner,  not to exceed sixty (60) days.
             Licensee shall at its discretion negotiate with Bio-Products either
             to  fully   finance  the   Bio-Products   facility,   to  partially
             participate  with a Bio-Products'  Third Party financial  entity in
             financing  the  facility,  or to not  participate  in the facility.
             After negotiations are concluded, which shall not exceed sixty (60)
             days  from  the  date  Bio-Products  submits  its  proposal  on the
             economic  feasibility,  and  regardless  of  whether  the  Licensee
             participates,  the Licensee  shall,  if requested by  Bio-Products,
             then grant site-specific  sub-licenses to Bio-Products or an entity
             in which  Bio-Products  owns  controlling  interest  that shall own
             and/or   operate  the   facility.   For   Bio-Products   facilities
             constructed  and  operated  under this  provision  and in which the
             Licensee has no financial  interest,  Licensee shall be paid twenty
             percent  (20%)  of any  royalties  paid to  Bio-Products  from  the
             operation of the facility.  Bio-Products  may construct and operate
             up to a total of four (4)  facilities  in the  States  of  Alabama,
             Tennessee,  Georgia, and South Carolina utilizing the Technology in
             which  the  Licensee  may have no  financial  interests  while  the
             exclusivity  of the Agreement  with  Licensee  remains in force and
             effect.

         2.2 The term of this license  shall extend from the  effective  date of
the original Technology License Agreement,  which is June 21, 2002, for a period
of twenty (20) years,  unless  extended,  terminated or replaced by agreement of
the Parties hereto,  or unless  otherwise  extended or terminated,  as elsewhere
provided in this Agreement. This Agreement shall be extended automatically until
the  expiration  date of the last  patent  issued  to  Bio-Products  and/or  UAH
covering the Technology.

         2.3 Anything to the  contrary  contained  elsewhere  in this  Agreement
notwithstanding,  Bio-Products  shall retain all of the exclusive rights granted
under the UAH License and all of the  exclusive  rights  obtained by  assignment
from Malley,  including the worldwide  exclusive right to license some or all of
its rights not granted to the Licensee  under this Agreement to Third Parties to
utilize the Technology.

         2.4 Subject to the terms and conditions of this Agreement, Bio-Products
hereby grants to Licensee the right to obtain an exclusive  option or license to
utilize the Technology to construct and operate  commercial scale MSW processing
and  recycling   facilities   outside  the  United  States  upon  the  following
conditions:

         (a) From the  date of this  Amended  and  Restated  Technology  License
             Agreement,  Bio-Products  agrees to inform  Licensee of any written
             offers from a Third Party to obtain an exclusive  option or license
             for a foreign  country not currently  under an exclusive  option or
             license  that  is  acceptable  to  Bio-Products.  Licensee  will be
             granted a period of thirty (30) days from the date of  notification
             in which to  elect to  purchase  the  option  or  license  for said
             country  on the same  terms  and  conditions  as  contained  in the
             written offer from the Third party. If Licensee exercises its right

                                Exhibit 10.6 - 4
<PAGE>
             to  purchase  the option or  license  for said  country  during the
             thirty (30) day period,  then Bio-Products shall grant an exclusive
             option or license to Licensee under the terms and conditions stated
             in the written  offer from the Third  Party.  If Licensee  fails to
             exercise  its right to  purchase  the option or license  within the
             thirty (30) day period,  then  Bio-Products  may grant an exclusive
             option or license for said  country to the Third  Party  making the
             initial offer.

         (b) The  Licensee  may from time to time  submit a written  request  to
             Bio-Products  naming  each  country in which it wishes to obtain an
             option  for an  exclusive  license to utilize  the  Technology.  If
             Bio-Products  has not  previously  granted an  exclusive  option or
             license to or received a written  offer from a Third Party for that
             country,  Bio-Products  shall  grant  Licensee  an  option  for  an
             exclusive  license  for that  country  upon the  payment of fifteen
             thousand  dollars  ($15,000) per country (the "Option  Fee").  Said
             Option Fee shall be due and payable  within  thirty (30) days after
             Bio-Products has informed  Licensee in writing that said country is
             available.  Licensee  acknowledges that the deadline for submission
             of  foreign  patent  applications  based  on the PCT  has  expired,
             therefore no patent  protection  can be provided to Licensee  under
             the PCT.  However,  Licensee  agrees to pay all fees and  expenses,
             including,  but not limited to,  maintenance  fees  incurred in the
             prosecution  of future patents as may be necessary or useful in the
             countries  licensed  to Licensee  under this  Paragraph  2.4.  Such
             option for an  exclusive  license  granted to Licensee  pursuant to
             this  Paragraph  2.4(b) shall be for a term of three (3) years from
             the date that the Option Fee is paid to Bio-Products;  provided the
             Licensee has also paid all fees and expenses for patent prosecution
             incurred  during  the  term  of  the  option  and  Licensee  is  in
             compliance   with  all   requirements   under  this  Agreement  for
             exclusivity in the United States.

         (c) At any time prior to the expiration of the term of an option for an
             exclusive  license to Licensee in any country  under  Paragraph 2.4
             (b),  the option may be  converted  to an  exclusive  license  upon
             payment by Licensee to Bio-Products of a license fee of eighty-five
             thousand  dollars  ($85,000) per country,  in addition to the above
             Option Fee and any patent  prosecution fees and expenses.  Licensee
             shall also  continue to pay all fees and expenses,  including,  but
             not limited to,  maintenance  fees incurred in the  prosecution  of
             patents as may be  necessary  or useful in the country  licensed to
             Licensee under this Paragraph 2.4.

         (d) For each  country  exclusively  licensed  to  Licensee  under  this
             Paragraph 2.4, the terms and conditions set forth elsewhere in this
             Agreement shall apply and  Licensee  shall pay royalties,  bonuses,
             and fees to  Bio-Products in accordance with Article III, excluding
             Paragraph 3.1, and  all  waste  processing  facilities  both in the
             United  States and outside the United States shall be combined on a
             cumulative  basis for purposes of  calculating  all payments due to
             Bio-Products,  unless  another  financial  arrangement  is mutually
             agreed to by the Parties.

                                Exhibit 10.6 - 5
<PAGE>
             ARTICLE III - FEES, ROYALTIES, AND OTHER CONSIDERATION
             ------------------------------------------------------
         3.1 The  Licensee  shall  pay to  Bio-Products  a one  time  Technology
licensing fee of Three Hundred Fifty Thousand Dollars  ($350,000).  Bio-Products
acknowledges  receipt of payments in the sum of One Hundred  Eighty Two Thousand
Five Hundred  Dollars  ($182,500).  The  remaining  balance of One Hundred Sixty
Seven Thousand Five Hundred Dollars  ($167,500) shall be paid within  twenty-six
(26) months from the effective date of this Agreement,  but no later than August
21,  2004.  Payments  of  said  fee  shall  be  by  either  wire  transfer  to a
Bio-Products bank account,  cashier's check, or other bank certified  negotiable
instrument on or before the date the payment becomes due and payable.

         3.2 The  Licensee  shall pay to  Bio-Products  a royalty of fifty cents
($.50) for every ton of waste received and processed  utilizing the  Technology,
up to a maximum of two  thousand  (2,000) tons per day of waste  processed.  The
Licensee shall pay to Bio-Products a royalty of one dollar ($1.00) for every ton
of waste  received and  processed in excess of two thousand tons per day up to a
maximum of ten thousand  (10,000) tons per day of waste processed.  The Licensee
shall pay to  Bio-Products  a royalty of one dollar and fifty cents  ($1.50) for
every ton of waste  received and  processed  in excess of ten thousand  (10,000)
tons per day. The royalty  payments shall become payable on the thirtieth (30th)
day following the end of the calendar month in which such amount becomes due and
owing until this  Agreement or any extension  thereof  expires or is terminated.
Bio-Products  agrees that no royalty  shall be due and payable  with  respect to
waste  processed at any facility  until such  facility has been in operation for
thirty  (30)  Operating  Days,  as defined in  Paragraph  1.3 (the  "Operational
Date").  Bio-Products  further  agrees that no royalty  shall be assessed on the
first facility until either the sale of the cellulose  product is confirmed by a
written  agreement  between the  Licensee  and a purchaser  or the  facility has
operated, producing and disposing of the cellulose product, for more than ninety
(90) days after the Operational Date. Payment of said royalties shall be by wire
transfer of funds to a Bio-Products  bank account or by cashier's check or other
bank certified negotiable instrument.

         3.3 The Licensee shall pay to Bio-Products a bonus (the "Bonus") of two
and one half  percent  (2.5%) of the gross  sales price in excess of ten dollars
($10.00) per ton for the cellulosic product from waste, including MSW, utilizing
the Technology.  The Bonus shall become due and payable on the ninetieth  (90th)
day following the end of the calendar  quarter in which such recyclable  product
sales are made until  this  Agreement  or any  extension  thereof  expires or is
terminated.  The Bonus shall be paid by wire transfer of funds to a Bio-Products
bank  account  or by  cashier's  check or by  other  bank  certified  negotiable
instrument.  The above  notwithstanding,  no Bonus shall be due and payable with
respect to the  cellulosic  product  produced at the facility until the facility
reaches its Operational Date.

         3.4 As additional  consideration  and for their experience and know-how
regarding the Technology,  the Licensee shall pay Bio-Products a monthly fee for
technical services.  Such technical services shall initially be provided by Eley
and Malley who are employees of Bio-Products,  and who agree to provide whatever
technical  services are  reasonably  requested of them by Licensee.  Payments to
Bio-Products for the technical  services shall be ten thousand dollars ($10,000)
per month  payable  on or before  the first  (1st)  business  day of each  month
beginning  six (6)  months  from the date  hereof.  Payments  for the  technical
services of Bio-Products shall be increased to twenty thousand dollars ($20,000)

                                Exhibit 10.6 - 6
<PAGE>
per month  commencing  on the first  business  day of the  month  following  the
Licensee's  initial down payment for the process vessels for construction of the
Licensee's  first plant and  continuing  each month  thereafter  until the first
facility  reaches its Operational  Date. After the Operational Date of the first
plant,  the monthly  technical  service fee shall be reduced to fifteen thousand
dollars ($15,000).  During any above period  Bio-Products shall provide whatever
services are reasonably requested of it by Licensee.

         If at any time  Bio-Products  fails  to  undertake  technical  services
requested,  then Licensee may cease all payments as set forth in this  Paragraph
3.4,  until  such  time as the  failure  to  undertake  the  technical  services
requested is remedied.

         Following the Operational Date of Licensee's  first facility,  Licensee
and  Bio-Products  shall enter into a  consulting  agreement  on terms  mutually
agreeable to both Parties for the continued  provision of technical  services by
Bio-Products  with respect to the  construction of additional  facilities or the
expansion of existing facilities. Licensee agrees that said consulting agreement
shall  include a minimum  annual  compensation  of One Hundred  Eighty  Thousand
Dollars  ($180,000) per year to be paid to Bio-Products in monthly  installments
for the first five (5) years  after the  Operational  Date of  Licensee's  first
facility.

         3.5  Additionally,  with respect to the technical  services provided by
Bio-Products,  the Licensee shall either provide  pre-paid  expense  accounts or
reimburse  Bio-Products  employees for the reasonable  transportation,  lodging,
food, and other expenses  incurred by Bio-Products  employees in the performance
of such technical  services for the Licensee.  In either case,  itemized expense
reports  and  receipts  shall  be  submitted  to the  Licensee  by  Bio-Products
employees  within ten (10)  business  days of completion of travel or a specific
project in which expenses are incurred.  The Licensee  shall  establish a travel
expense  policy and  procedure  which policy and  procedure  Bio-Products  shall
adhere to unless the parties agree, in writing, otherwise. Any reimbursement for
expenses shall be paid by the Licensee  within ten (10) business days of receipt
of such expense reports submitted by Bio-Products employees.

         3.6 The Licensee may enter into research and development contracts with
UAH unrelated to the Technology, with Eley as the principal investigator,  to be
defined from time to time in exchange for  results,  information,  and a royalty
free  unrestricted  license  to use  said  results  and  information  which  are
unrelated to the  Technology  at  Licensee's  facilities  for the period of this
Agreement  unless a separate  agreement is prepared and signed by both  Parties.
Such results and information  which are unrelated to the  Technology,  including
but not limited to test results, notes, and reports regarding the work performed
as  requested  by the  Licensee  shall be turned over to the Licensee by UAH and
Eley within thirty (30) days of completion, and all such results and information
shall be kept  confidential and shall not be disclosed in any form without first
obtaining  approval  from the  Licensee.  Any and all research  and  development
results   unrelated  to  the   Technology   from  contracts  with  Licensee  are
confidential  and may not be  provided  to Third  Parties  without  the  written
permission  of Licensee.  If permission is granted by Licensee for Third Parties
to use such unrelated  technology then Licensee shall be compensated at the rate
of 20% of  royalties  received  by  Bio-Products  for the  use of the  unrelated
technology by a Third Party.  UAH and Eley shall allow the Licensee to visit the
UAH pilot plant facility for any purposes, including demonstrations,  recyclable

                                Exhibit 10.6 - 7
<PAGE>
product  production,  and testing  upon  reasonable  notice by the  Licensee and
mutual  agreement  with Eley as to the dates and times.  UAH and Eley shall also
provide training for the Licensee's  employees to use the licensed Technology at
the UAH pilot plant. Eley shall be compensated at a rate of five hundred dollars
($500.00)   per  day  plus  expenses  for  all  pilot  plant   operations.   For
demonstrations,  recyclable product production, testing, and training at the UAH
pilot plant at the request of the Licensee,  the Licensee  shall  compensate UAH
for the expenses for such demonstration and test runs as follows:
         (a) For Each Series of Test Runs:
                (i)   Pilot Plant Preparation/Set up                 $500
                (ii)  Pilot Plant Clean-up/Shutdown                  $500
         (b) For Each Test Run in a Series:
                (i)   Boiler Fuel/Water Treatment                    $200
                (ii)  Labor                                          $800
                (iii) Waste Disposal                                 $100
         (c) Follow up Costs:
                (i)   Small Sample Collection, Packaging & Storage   $100
                (ii)  Large Sample Collection & Packaging            $250
                (iii) Dry Cellulose Product per ton                  $500
                (iv)  Shipping Containers & Shipping Costs      Actual, plus 25%
         (d) Additional expenses:
                (i)   Tractor Rental                                 $100/day
                (ii)  Auto/Truck mileage for Laborers                $0.40/mile
                (iii) Truck towing mileage                           $0.80/mile
                (iv)  Local Lodging for Laborers                     $50/day
                (v)   Per Diem allowance for Laborers                $25/day

         3.7 For the first facility to be sub-licensed under this Agreement, the
Licensee agrees that the facility design,  equipment designs and specifications,
equipment  fabricator for the process  vessel,  engineering  firm,  construction
contractors and sub-contractors, and all facility management and labor personnel
must be approved  by  Bio-Products,  which  approval  shall not be  unreasonably
withheld.  The Licensee also agrees to begin the facility  permitting,  facility
and  equipment  design,  equipment  selection,  and  engineering  for the  first
facility  within six (6) months from the date of execution of this Agreement and
to begin placing orders for equipment and construction  site work within one (1)
year from the date of approval of all permitting, facility and equipment design,
equipment selection, and engineering for the first facility. Notwithstanding the
foregoing,  Licensee shall begin placing orders for equipment and shall commence
and diligently pursue construction and completion of the first facility no later
than thirty (30) months from the effective date of this  Agreement,  which would
be December 21, 2004.

         3.8 Due to the  proprietary  nature of the process vessel  design,  the
Licensee agrees that  Bio-Products  shall maintain the exclusive right of vessel
manufacture,  and the Licensee and its Sub-licensees shall purchase all required
vessels  exclusively  from  Bio-Products.  The purchase price shall be cost plus
fifteen  percent  (15%),  not  including  shipping  costs or  taxes.  All  other
equipment  required  for  construction  and  operation of waste  processing  and
recycling  facilities  utilizing  the  Technology  may be  purchased  from other
vendors.  The first two vessels are to be built to Bio-Products'  specifications
in  Mississippi  and  shipped to the  requested  locations.  Shipping  costs and
applicable taxes shall be itemized and included in the cost of vessels and shall
be invoiced to and paid by the  Licensee.  Thereafter,  Bio-Products  shall from
time  to time  seek  the  qualifications  of and  obtain  cost  quotations  from

                                Exhibit 10.6 - 8
<PAGE>
alternative vessel manufacturers to manufacture future process vessels as needed
such that the same may be provided to Licensee  having  equal or higher  quality
than that established by Bio-Products from its Mississippi  manufacturer and may
be transported by truck to the required facility at a cost equal to or less than
that established by Bio-Products from its Mississippi manufacturer including the
cost of shipping and taxes. If future vessels are purchased at a cost, excluding
shipping costs and taxes, below the most recent purchase price,  Licensee agrees
to pay  Bio-Products  an amount equal to  twenty-five  percent (25%) of the cost
savings.

         3.9 In  order  to  maintain  the  exclusivity  of this  Agreement,  the
Licensee further agrees that, within six (6) months from the Operational Date of
the first facility,  the Licensee shall begin the facility permitting,  facility
and equipment design,  equipment selection,  and engineering for construction of
one or more  facilities  with a combined total of at least two thousand  (2,000)
tons per day.  Licensee  further  agrees  that  within  three (3)  months  after
Licensee has obtained  approval of  permitting,  facility and equipment  design,
equipment  selection,  and  engineering,   the  Licensee  shall  begin  ordering
equipment  and  construction  site  work for the one or more  facilities  with a
combined total of at least two thousand  (2,000) tons per day, unless  prevented
from doing so by a regulatory  or government  agency,  acts of God, acts of war,
acts of terrorism,  strikes,  and the like. The Licensee  shall expand  existing
facilities  and/or add new  facilities  with design  capacity for  processing at
least an average of an additional two thousand  (2,000) tons per day of MSW each
year  thereafter,  unless  prevented from doing so by a regulatory or government
agency.  If Licensee fails to perform as specified  under this Paragraph 3.9 for
two (2) consecutive  years,  then this Agreement shall convert from an exclusive
to a non-exclusive license.

         3.10 The  Licensee  shall  maintain  all such books and  records as are
necessary to accurately  determine all amounts due and payable to  Bio-Products,
Eley, and Malley under Paragraphs 3.2, 3.3, 3.4 and 3.5 of this Agreement, which
books and  records  the  Licensee  shall  make  reasonably  available,  upon the
submission of a written request from Bio-Products for inspection by Bio-Products
and/or  its  designated   representative  at  a  time  mutually   convenient  to
Bio-Products and the Licensee. Bio-Products agrees to treat all such information
respecting Licensee's books and records as confidential.

         3.11 All payments  shall be paid to  Bio-Products  at the addresses set
forth in Paragraph  14.15 of this Agreement or as otherwise  notified in writing
by the Parties.

                     ARTICLE IV - INVENTIONS AND DISCOVERIES
                     ---------------------------------------
         4.1 All rights,  title,  and interest in and to the  Technology and all
patent  applications and patents thereon or relating thereto as presently exist,
both  foreign and  domestic,  shall  remain the sole and  exclusive  property of
Bio-Products  and/or UAH. In  addition,  patents and patent  applications,  both
foreign and domestic,  with respect to the existing  Technology shall be applied
for and  prosecuted,  and if received,  shall issue solely in  Bio-Products'  or
UAH's name.

         4.2 All right,  title and  interest  in and to all  future  inventions,
processes,   enhancements,   improvements   and   other   discoveries   made  by
Bio-Products,  or any person acting for and under the direction of  Bio-Products

                                Exhibit 10.6 - 9
<PAGE>
or the  Licensee,  or any  other  employee  or  agent  of  Bio-Products,  or the
Licensee,  relating to the Technology shall be owned by Bio-Products and/or UAH.
All patent applications and patents thereon, foreign and domestic,  whether made
by any of the Parties or UAH, or jointly by the Parties and UAH or jointly by at
least one employee of each Party,  shall be owned  exclusively  by  Bio-Products
and/or UAH.  Bio-Products  shall provide the Licensee with detailed  information
concerning  all  such  related,  future  inventions,  processes,   enhancements,
improvements  and other  discoveries  upon  request.  To the extent  required to
accomplish the foregoing,  the Licensee shall execute any and all assignments of
patents or other documents to Bio-Products  and/or UAH, if required for any such
patents to issue in Bio-Products' or UAH's name.  Bio-Products  hereby grants to
the Licensee an exclusive license in the USA, subject to the same exclusions and
conditions stated above in Paragraph 2.1, to utilize all such future inventions,
processes,  enhancements,  improvements  and other  discoveries at no additional
royalty or cost,  except  that the term of this  Agreement  shall be extended by
agreement  of the  Parties  or  automatically  to  the  expiration  date  of any
subsequently issued patent.

         4.3 The  Technology of  Bio-Products  and/or UAH shall be maintained by
the Licensee free and clear of all liens and encumbrances or rights of any Third
Party. Neither Bio-Products nor Licensee shall sub-license,  encumber,  transfer
or assign the Technology of Bio-Products  and/or UAH without the written consent
of the other party, except as provided in this Agreement.
         4.4 The  provisions  of this  Article  shall apply to both  foreign and
domestic inventions, processes, enhancements, improvements and other discoveries
relating to the Technology and to all patent  applications  and patents  related
thereto.

         4.5 The  Parties  shall  cooperate  in good faith to  protect  any such
invention, process, enhancement, improvement or other discovery, and to make all
necessary applications,  assignments, as provided herein, and filings, including
patents,  industrial designs,  copyright registrations,  trademark registrations
and other legal  protections,  necessary or helpful to protect  their  interests
therein.

                    ARTICLE V - REPRESENTATIONS AND WARANTIES
                    -----------------------------------------
                                 OF BIO-PRODUCTS
                                 ---------------
         Bio-Products hereby represents and warrants,  as of the date hereof, as
follows:

         5.1 Bio-Products is a corporation, duly organized, validly existing and
in good standing under the laws of Alabama. Bio-Products has all requisite power
and  authority,  corporate and  otherwise,  to execute,  deliver,  observe,  and
perform its  obligations  under,  this  Agreement.  The execution,  delivery and
performance by  Bio-Products  of this Agreement have been duly authorized by all
necessary  corporate  action  and does not and  will not  violate  Bio-Products'
Articles of  Incorporation  or Bylaws or any  provision of any  agreement,  law,
rule, regulation, order, writ, judgment, injunction,  decree, determination,  or
award presently in effect to which Bio-Products is a party or is subject.

                                Exhibit 10.6 - 10
<PAGE>
         5.2 Bio-Products possesses all such franchises,  licenses,  patents, or
other rights  necessary to enter into, and satisfy its obligations  under,  this
Agreement,  without (to the best of Bio-Products'  knowledge) any conflict with,
or infringement of, the franchises,  licenses,  patents or other rights of Third
Parties.

         5.3  Bio-Products  has the exclusive rights to grant some or all of its
rights or licenses to Third Parties to utilize the Technology not granted to the
Licensee under this Agreement in various geographical locations worldwide.

         5.4 There is no action,  suit,  proceeding  or claim pending or, to the
knowledge of Bio-Products,  threatened against  Bio-Products in any way relating
to the Technology.  There is no action, suit, proceeding or claim pending or, to
the knowledge of  Bio-Products,  threatened  against  Bio-Products'  properties,
assets or business which might have a materially adverse effect on Bio-Products'
rights or ability to perform this  Agreement in  accordance  with its terms.  No
investigation  by any  governmental  agency is  pending  or  threatened  against
Bio-Products or the properties, business, or goodwill of Bio-Products, which has
or might have a materially adverse effect on Bio-Products'  rights or ability to
perform this  Agreement in accordance  with its terms.  There is no  outstanding
order,  writ,  injunction,  or decree of any court,  government or  governmental
agency against Bio-Products or its assets,  business, or goodwill.  Bio-Products
is not in violation of any law or governmental  regulation  applicable to it, to
the Technology,  or to its properties or business,  including but not limited to
any applicable safety, environmental control, or similar law or regulation.

         5.5 There is no claim or demand of any Third  Party  pertaining  to, or
any  proceedings,  which are  pending  or,  to the  knowledge  of  Bio-Products,
threatened  which  challenge the rights of Bio-Products in respect of any of the
Technology.  No technology owned, licensed or used by Bio-Products is subject to
any outstanding order,  decree,  judgment,  or stipulation by or with any court,
arbitrator or administrative agency, or, to the best of Bio-Products' knowledge,
infringes upon the rights of Third Parties.

         5.6 Bio-Products reserves the right to, but as of the effective date of
this  Agreement has not, put any Third Party on notice of, and is not a party to
any suit  alleging,  any  infringement  or  alleged  infringement  of any of the
Technology.  Bio-Products  is aware that there are  currently  bases for putting
certain  Third Parties on notice and/or  filing  claims,  action,  or litigation
alleging infringement of the Technology.

                      ARTICLE VI - INDEMNITY AND INSURANCE
                      ------------------------------------
         6.1  (a) The  Licensee  shall  indemnify,  defend and hold Bio-Products
                  and UAH and their respective directors, trustees, officers and
                  employees  harmless  from and  against  any and all claims and
                  expenses, including reasonable attorneys' fees and other legal
                  expenses,  arising out of the death or injury of any person or
                  persons,   any  damage  to  property,   or  any  other  claim,
                  proceeding,   demand,   expense,  or  liability  of  any  kind
                  whatsoever  resulting  from, or attributable to utilization of
                  the Technology (see Paragraph 10.3 below and Exhibit A).

                                Exhibit 10.6 - 11
<PAGE>
              (b) At  least  ten  (10)  days  prior to  commencement  of  vessel
                  installation  and  operating  activities  on the  site of each
                  facility  of the  Licensee to be  constructed  and utilize the
                  Technology  pursuant to this  Agreement,  the  Licensee or its
                  Sub-licensee   shall   provide  to   Bio-Products   copies  of
                  certificates  evidencing the purchase of policies of insurance
                  against the liabilities  described in Paragraph 6.1(a), naming
                  UAH and all of the Parties hereto as additional  insureds,  in
                  amounts not less than one  million  dollars  ($1,000,000)  per
                  claim.

              (c) Bio-Products  facilities  in which the Licensee  shall have no
                  financial interest shall provide indemnification and insurance
                  against the  liabilities  described in  Paragraph  6.1 (a) and
                  (b),  naming UAH and all of the Parties  hereto as  additional
                  insureds,  in  amounts  not  less  than  one  million  dollars
                  ($1,000,000) per claim.

                            VII - PATENT INFRINGEMENT
                            -------------------------
         7.1  (a) Bio-Products  shall  notify  the  Licensee,  and  the Licensee
                  shall notify Bio-Products,  of any infringement suits that may
                  be brought  against any Party to this  Agreement  within three
                  days after  learning of the  existence  thereof.  Bio-Products
                  and/or UAH shall defend at their own expense all  infringement
                  suits  relating  to the  existing  Technology,  and any future
                  discoveries,    inventions,    improvements,   processes   and
                  enhancements  described  in  Paragraphs  4.1  and  4.2 of this
                  Agreement.  In  connection  with the  defense by  Bio-Products
                  and/or UAH of any Third Party claim,  the Licensee  shall take
                  reasonable  actions as are  necessary  or  desirable to assist
                  Bio-Products and/or UAH in any such action. If the Licensee is
                  called upon to take action in a way,  which require it to make
                  available  its  own  personnel  or to  retain  counsel  and/or
                  experts,  Bio-Products  shall  reimburse  the Licensee for the
                  direct costs of the Licensee's  personnel involved and for the
                  fees and  disbursements  incurred on account of the Licensee's
                  counsel and experts.  Such reimbursement of the Licensee shall
                  be by deduction from amounts to be paid to Bio-Products by the
                  Licensee for use of the Technology under this Agreement.

              (b) The Licensee shall at its own expense defend all  infringement
                  suits   relating   to  any   variations,   modifications   and
                  alterations of the  Technology  that were made by the Licensee
                  without   the   written   acknowledgement   and   consent   of
                  Bio-Products to make any such variations,  modifications,  and
                  alterations  of the  Technology.  The  Licensee  shall  not be
                  entitled to any  deduction  from amounts due  Bio-Products  on
                  account of such expenses.

         7.2 Bio-Products  shall have the sole right (but not the obligation) to
take enforcement  action against or settle  infringement  activity arising under
any of the patents  covering the  Technology.  If Bio-Products is unable to take
enforcement  action or  settle  infringement  activity  for  financial  reasons,
Bio-Products  may  request  Licensee  to  provide   financing  to  jointly  with

                                Exhibit 10.6 - 12
<PAGE>
Bio-Products take such action. Licensee shall, at its sole discretion, determine
whether to provide the  financial  resources  for any such action.  The Licensee
shall take all reasonable actions as are necessary to assist Bio-Products in any
such action. If the Licensee is called upon to take action in a way, which shall
require it to make  available  its own  personnel  or to retain  counsel  and/or
experts,  Bio-Products  shall  reimburse the Licensee for the direct cost of the
Licensee's  personnel  involved and for the fees and  disbursements  incurred on
account  of the  Licensee's  counsel  and  experts.  Such  reimbursement  of the
Licensee  shall be by deduction from amounts to be paid to  Bio-Products  by the
Licensee for use of the Technology under this Agreement.

         7.3 In connection  with the defense by  Bio-Products of any Third Party
claims not addressed in Paragraphs  7.1 or 7.2, the Licensee  shall  participate
and cooperate,  as Bio-Products shall, from time to time, reasonably request. If
the  Licensee is called  upon to take action in a way which shall  require it to
make  available  its own  personnel or to retain  counsel  and/or  experts,  the
Licensee  shall be  entitled to a  deduction  from any amounts due  Bio-Products
under this Agreement.  If there are no such amounts due Bio-Products  under this
Agreement,  then  Bio-Products  agrees to pay Licensee all  personnel,  counsel,
expert and courts costs thirty days after  notification  of such expenses by the
Licensee in connection with Bio-Products' defense of such suits.

                   ARTICLE VIII - FABRICATION AND CONSTRUCTION
                   -------------------------------------------
         8.1 The  Licensee  shall  use its  best  efforts  to  assure  that  all
construction  and fabrication  meets or exceeds all required safety standards of
the United States and the jurisdiction wherein the Technology shall be utilized.

         8.2 Bio-Products  will use its best efforts to assure that all designs,
processes,  formulas,  recipes, and plans to be provided to the Licensee meet or
exceed all applicable and material safety standards of the United States and any
jurisdiction wherein the Technology shall be utilized.

         8.3 The Licensee  shall use its best efforts to obtain,  or cause to be
obtained,  all  material  local,  state and federal  permits  necessary  for the
construction and operation of any facility that will utilize the Technology.

                          ARTICLE IX - CONFIDENTIALITY
                          ----------------------------
9.1 The Parties hereto each possess confidential information of both a technical
and a  non-technical  nature.  It is  understood  that  it has  been  and may be
necessary  for one to disclose  same to the other,  and the  Parties  agree such
disclosures have been and will be made under and subject to the following terms:

              (a) Each Party agrees to receive and maintain in strict confidence
                  the  confidential  information  disclosed  to it by the  other
                  Party and which is designated in writing as  "CONFIDENTIAL" by
                  the   Party   making   the   disclosure.   Such   confidential
                  information,  either tangible or intangible, shall not be used
                  in any way other than for performance of express provisions of
                  this  Agreement,  and shall not be disclosed to others without
                  written consent of the designating, disclosing Party.

              (b) The obligations of  confidentiality  herein shall not apply to
                  prevent any Party  hereto from using or  otherwise  disclosing
                  any information, tangible or intangible, which:

                                Exhibit 10.6 - 13
<PAGE>
                  (i)  it had rightfully in its possession before the disclosure
                       thereof by the disclosing Party;
                  (ii) is  now  in,  or  later  comes  into,  the public  domain
                       through no fault of the receiving Party; or

                  (iii)is  disclosed  to  the  receiving  Party by a Third Party
                       having the right to make such a disclosure.

              (c) The obligations of confidentiality  herein shall extend beyond
                  any termination,  cancellation or expiration of this Agreement
                  and  shall  include  all such  written  information  exchanged
                  between the Parties.

              (d) The  information   designated  as   "CONFIDENTIAL"   shall  be
                  disclosed by each Party only to those employees  having a need
                  to know same for purposes of performing the express provisions
                  of this Agreement,  and who shall in writing agree to be bound
                  by the provisions of this Paragraph 9.1.

              (e) The Parties to this Agreement shall take all necessary care to
                  maintain all "CONFIDENTIAL"  information in strict confidence.
                  Disclosure  to any Third  Party  shall be made only after said
                  Third Party has executed a  "Confidentiality,  Non-Disclosure,
                  and  Non-Competition"  agreement  which is attached  hereto as
                  Exhibit  F,  copies  of  which  shall  be  maintained  by  the
                  disclosing  Party and shall be subject to inspection by any of
                  the Parties hereto.

              (f) In the event that any Party hereto becomes  legally  compelled
                  or otherwise  legally  obligated to disclose any  confidential
                  information  disclosed to it by another  Party,  the compelled
                  Party will provide the other Party  prompt  notice so that the
                  other Party may seek a protective  order or other  appropriate
                  remedy.  Should the other Party be unable on its own behalf to
                  obtain such order or remedy,  the compelled Party will use its
                  best efforts to obtain a protective order or other appropriate
                  remedy and if unable to do so will consult (or will cause such
                  person to whom such confidential  information was furnished to
                  consult)  with the other Party as to what  information  should
                  and  should  not be  disclosed  and will  disclose  only  that
                  portion  of the  confidential  information  which  is  legally
                  required  to be  disclosed  and will use its best  efforts  to
                  obtain   assurances   that  treatment   consistent  with  this
                  paragraph will be accorded to that portion of the confidential
                  information  so disclosed.  Except for expenses  incurred as a
                  result  of  any  breach  of  this  Agreement  relating  to the
                  disclosure of confidential  information,  the other Party will
                  reimburse  the  compelled  Party for its expenses  incurred in
                  complying with the terms of this Paragraph 9.1 (f).

              (g) The Parties  hereto  agree to  collect,  obtain and deliver to
                  each other at the  expiration or earlier  termination  of this
                  Agreement, all documents,  models,  drawings,  plans, designs,
                  specifications, calculations, memoranda and other materials or
                  records prepared in the course of their performance and duties

                                Exhibit 10.6 - 14
<PAGE>
                  hereunder,  except one record  set,  which may be  retained by
                  each Party in accordance with the provisions of this Paragraph
                  9.1.

               ARTICLE X - AGREEMENT BETWEEN BIO-PRODUCTS AND UAH
               --------------------------------------------------
         10.1 Bio-Products shall comply with all of the terms and conditions of,
and perform all of its obligations  under, the UAH License.  Bio-Products  shall
not  agree to any  amendment  or  modification  of the UAH  License  that  would
materially affect the terms and conditions of this Agreement without the written
consent of Licensee.

         10.2 If at any time  Bio-Products  defaults in its duties in connection
with, or by its conduct attempts to or actually terminates the UAH License which
default and/or termination  affects or terminates the ability of Bio-Products to
grant  the  license  contained  in this  Agreement,  then the  Licensee  will be
automatically  entitled to and may at its sole discretion enter into contractual
agreements  with and pay  directly  to UAH the  amounts  necessary  to obtain or
maintain the UAH License. If Licensee does not enter into contractual agreements
with UAH, but rather cures any financial default of Bio-Products only, then such
sums paid to UAH on behalf of Bio-Products  shall be deducted from any royalties
owed to  Bio-Products  under this  Agreement.  If no such  royalties are owed to
Bio-Products  under this Agreement then such sums will be treated as an interest
free loan to Bio-Products.

         10.3 Any provision of this  Agreement to the contrary  notwithstanding,
this  Agreement  shall  be  construed  and  interpreted  so that the  terms  and
conditions hereof shall not be inconsistent with the terms and conditions of the
UAH License, attached hereto as Exhibit A.

                        ARTICLE XI - PUBLICITY OF LICENSE
                        ---------------------------------
         11.1 Upon the request of the Licensee, Bio-Products shall cooperate and
provide assistance in the development of public statements,  advertising,  sales
literature or promotional materials to describe or promote the Technology.

                        ARTICLE XII - VISITS TO PREMISES
                        --------------------------------
         12.1 The Licensee  shall,  from time to time,  permit  Bio-Products  to
bring visitors to tour any facility  utilizing the  Technology,  provided,  that
Bio-Products  shall  notify  the  Licensee  at least  seventy-two  (72) hours in
advance of any proposed  visit,  that such visits shall be limited to reasonable
times and  intervals,  and contingent  upon each visitor  signing an appropriate
Confidentiality, Non-Disclosure and Non-Competition Agreement, and such visitors
shall also be subject to all relevant safety and other regulations that apply to
any other  visitors to the facility.  No persons other than those  designated by
Bio-Products shall have the right to visit any facility utilizing the Technology
without the Licensee's express written consent.

                  ARTICLE XIII - EVENTS OF DEFAULT AND REMEDIES

         13.1 The Licensee shall be in breach of this Agreement in the event of:

                                Exhibit 10.6 - 15
<PAGE>
              (a) The  Licensee's  failure to make any payment  hereunder  on or
                  before the date on which such payment  becomes due and payable
                  and the  continuation  of such failure  unremedied  for thirty
                  (30) days after written  notice  thereof has been given to the
                  Licensee by Bio-Products;

              (b) The  Licensee's  failure to observe or perform  any  covenant,
                  condition or agreement  contained  in this  Agreement  and the
                  continuation  of such failure  unremedied for thirty (30) days
                  after written notice thereof has been given to the Licensee by
                  Bio-Products,  unless such  breach can not be remedied  within
                  such  thirty  (30)  days for  reasons  beyond  the  Licensee's
                  control,  in which case the  Licensee  shall have a reasonable
                  time within which to remedy such breach; or

              (c) Any warranty or representation made herein by the Licensee and
                  contained in this  Agreement,  shall prove to have been false,
                  misleading or incorrect in any material respect as of the date
                  made, or shall have failed to state a fact  necessary in order
                  to make the statements made not misleading.

         No  termination  of this  Agreement  shall  relieve the Licensee of the
obligation  to pay to  Bio-Products  all  royalties,  fees,  and other  payments
accrued at the time of the termination.

         13.2 Bio-Products  shall  be  in default of this Agreement in the event
 of:

              (a) Bio-Products'  failure to observe  or  perform  any  covenant,
                  condition or agreement  contained in this  Agreement or in the
                  UAH License and the  continuation  of such failure  unremedied
                  for thirty (30) days after written  notice  thereof shall have
                  been given to Bio-Products by the Licensee;

              (b) Any warranty or representation  made herein by or on behalf of
                  Bio-Products,  contained  in  this  Agreement  or in  the  UAH
                  License,  shall  prove  to  have  been  false,  misleading  or
                  incorrect  in any  material  respect as of the date  made,  or
                  shall have failed to state a fact  necessary  in order to make
                  the statements made not misleading; or

              (c) If  at  any  time  Bio-Products  defaults  in  its  duties  in
                  connection  with,  or by its  conduct  attempts to or actually
                  terminates  the UAH License which default  and/or  termination
                  affects or terminates the ability of Bio-Products to grant the
                  license contained in this Agreement,  or affects or terminates
                  Licensee's ability to continue operation of existing plants or
                  build new plants.

         13.3 The  Licensee  shall  have the  following  remedies  for breach or
default of this Agreement or the UAH License by Bio-Products:

              (a) Upon Bio-Products' breach or termination of the UAH License or
                  this  Agreement,  such  that the  breach  or  termination  has
                  affected  the ability of Licensee  to  continue  operation  of

                                Exhibit 10.6 - 16
<PAGE>
                  existing  plants and  preclusion  of building new plants,  the
                  Licensee  may at  its  option  terminate  this  Agreement  and
                  contract directly with UAH as provided in this Agreement., The
                  Licensee and any  sub-licensee  shall utilize the  Technology,
                  free of any royalties, fees, and other amounts accrued through
                  the date of such default or breach and thereafter.

              (b) In  addition  to any other  right or remedy  available  to the
                  Licensee  under  this  Agreement  or in  law or  equity,  upon
                  Bio-Products'  breach or default of this  Agreement or the UAH
                  License,  the  Licensee  shall be entitled to withhold  and/or
                  offset any and all royalties or other fees due to Bio-Products
                  under this Agreement.

              (c) Notwithstanding  anything to the  contrary in this  Agreement,
                  the Licensee may terminate this Agreement at any time upon six
                  (6) months prior written notice to Bio-Products, at which time
                  the Licensee will cease utilizing the  Technology,  and pay to
                  Bio-Products  any  royalties,  fees and other amounts  accrued
                  through  the  date  of  such  termination.   Immediately  upon
                  termination  of this  Agreement  all  rights,  privileges  and
                  licenses  granted to the  Licensee  hereunder  shall revert to
                  Bio-Products, including all sub-licenses of facilities granted
                  by the Licensee.

         13.4 Upon the  Licensees'  breach of this Agreement and it's failure to
cure said breach as provided above in 13.1, Bio-Products may, at its option, (i)
terminate  this  Agreement,  at which time  Licensee  shall cease  utilizing the
Technology and such termination shall relieve Licensee of its obligations to pay
Bio-Products  any further  royalties or fees other than those fees and royalties
already accrued through the date of termination and all sub-licenses  granted by
Licensee shall be assigned to  Bio-Products;  or (ii)  Bio-Products may seeks to
recover such damages to which it may be entitled by  applicable  law,  including
but not limited to, equitable and injunctive relief.

         13.5 (a) Any  claim  or  controversy  arising  out  of  or  relating to
                  this  Agreement,  or the  breach  thereof,  including  without
                  limitation  the right of any Party  hereto to  terminate  this
                  Agreement,   shall   be   settled   by   binding   arbitration
                  administered  by  the  American  Arbitration   Association  in
                  accordance with its then current Commercial Arbitration Rules,
                  and judgment upon the award  rendered by the arbitrator may be
                  entered  in  any  court  having  jurisdiction   thereof.   The
                  arbitration  shall be  before  one  neutral  arbitrator  to be
                  selected  in  accordance  with  the  then  current  Commercial
                  Arbitration Rules of the American Arbitration Association. The
                  parties  shall  have all rights to  pre-arbitration  discovery
                  pursuant to the Federal Code of Civil Procedure.

              (b) Neither of the Parties nor the  arbitrator  may  disclose  the
                  existence,  content or results  of any  arbitration  hereunder
                  without the prior  written  consent of the  Parties  except to
                  counsel, accountants, and other need to know professionals.

                                Exhibit 10.6 - 17
<PAGE>
              (c) All fees and expenses of the arbitration  shall be born by the
                  Parties equally. However, each Party shall bear the expense of
                  its own  counsel,  experts,  witnesses,  and  preparation  and
                  presentation of proofs.

              (d) In the event that a claim or controversy over the right of any
                  Party to  terminate  this  Agreement  shall be  submitted  for
                  arbitration,  this Agreement  shall continue in full force and
                  effect,  and the termination shall be of no effect,  until the
                  arbitrator renders a final decision.

         13.6 In the event of the  commencement  of a  voluntary  case under the
Bankruptcy  Code by the Licensee,  or Licensee's  acquiescence in an involuntary
petition under the Bankruptcy Code which  voluntary or involuntary  case remains
undismissed  for a period of ninety  (90)  days or more,  the right and  license
conferred under this Agreement shall  automatically  become and shall thereafter
be null and void. The commencement of a voluntary case under the Bankruptcy Code
by Bio-Products,  or Bio-Products' acquiescence in an involuntary petition under
the Bankruptcy Code, which voluntary or involuntary case remains undismissed for
a period of ninety (90) days or more,  shall be treated as a material  breach of
the Agreement.

                        ARTICLE XIV - GENERAL PROVISIONS
                        --------------------------------
         14.1 The titles of the various  articles and sections of this Agreement
are solely for  convenience  of reference and are not part of this Agreement for
purposes of interpreting the provisions hereof.

         14.2 The Licensee may assign all of its rights and  obligations  under,
and all of its interest in, this  Agreement,  including  without  limitation the
license granted hereby,  either (i) in a transaction  accompanied by the sale or
other transfer of the Licensee's  entire  business,  its stock, or substantially
all of its assets, or (ii) to any other entity owned by the same shareholders of
Licensee and this Agreement  shall be binding upon, and inure to the benefit of,
any such  successor  or  assign  of the  Licensee,  provided  that  Bio-Products
consents in writing,  such  assignment  shall not be  unreasonably  conditioned,
withheld, or delayed..

         14.3  Nothing  in this  Agreement  shall  be  deemed  or  construed  to
constitute  or to create a  partnership,  joint  venture or agency  between  the
Parties.  Except as may be otherwise  provided herein,  neither Party shall have
any authority to bind the other Party in any respect.

         14.4 If any  provision of this  Agreement  is or becomes  unenforceable
under any law of mandatory  application,  it is the intent of the Parties hereto
that such provision will be deemed severed and omitted  herefrom,  the remaining
portions hereof to remain in full force and effect as written.

         14.5 The  waiver by any Party of any  failure  on the part of any other
Party to  perform  any of its  obligations  under  this  Agreement  shall not be
construed as a waiver of any failure or continuing failure or failures,  whether
similar or dissimilar thereto.

                                Exhibit 10.6 - 18
<PAGE>
         14.6 This  Agreement,  including the exhibits  hereto,  constitutes the
entire  Agreement  between the Parties with respect to the subject matter hereof
and supersedes  all prior and  contemporaneous  agreements  between the Parties,
whether oral or written,  related to the subject matter  hereof.  This Agreement
may be  amended  or  modified  only  by a  written  instrument  executed  by the
authorized representatives of the Parties hereto.

         14.7 This Agreement may be executed in one or more  counterparts,  each
of which shall be deemed to be a  duplicate  original,  but all of which,  taken
together,  constitute a single document.  This Agreement may be executed by each
Party on  separate  copies,  which  copies,  when  combined so as to include the
signatures  of all  Parties,  shall  constitute  a  single  counterpart  of this
Agreement.

         14.8 This  Agreement  shall be governed by and  construed in accordance
with the laws of the State of Alabama.

         14.9 Each Party to this  Agreement  shall execute all  instruments  and
documents and take all actions as may be reasonably  required to effectuate this
Agreement.

         14.10 For purposes of venue and  jurisdiction,  this Agreement shall be
deemed made and to be performed in the City of Huntsville, Alabama.

         14.11 This  Agreement  and all  exhibits  contain the entire  agreement
between the Parties to this Agreement with respect to the subject matter of this
Agreement,  is intended as a final  expression of such Parties'  agreement  with
respect  to such terms as are  included  in this  Agreement,  is  intended  as a
complete and exclusive statement of the terms of such agreement,  and supersedes
all negotiations, stipulations,  understandings, agreements, representations and
warranties,  if any,  with  respect to such  subject  matter,  which  precede or
accompany the execution of this Agreement.

         14.12  Whenever  the context so requires in this  Agreement,  all words
used in the  singular  shall be  construed  to have been used in the plural (and
vice versa), each gender shall be construed to include any other genders.

         14.13 Subject to any restriction on  transferability  contained in this
Agreement,  this Agreement  shall be binding upon and shall inure to the benefit
of the  successors-in-interest  and  permitted  assigns  of each  Party  to this
Agreement.  Nothing in this Paragraph shall create any rights enforceable by any
Third Party that is not a Party to this Agreement,  except for the rights of the
successors-in-interest  and permitted  assigns of each Party to this  Agreement,
unless such rights are expressly granted in this Agreement to other specifically
identified Third Parties.

         14.14 Except as otherwise provided in this Agreement,  in the event any
litigation,  arbitration,  mediation,  or  other  proceeding  ("Proceeding")  is
initiated  by any  Party  against  any  other  Party to  enforce,  interpret  or
otherwise  obtain  judicial or  quasi-judicial  relief in  connection  with this
Agreement,  the prevailing Party in such Proceeding shall be entitled to recover
from the unsuccessful Party all costs,  expenses, and reasonable attorneys' fees
relating  to or  arising  out of  (a)  such  Proceeding  (whether  or  not  such
Proceeding  proceeds  to  judgment),  and (b) any  post-judgment  or  post-award

                                Exhibit 10.6 - 19
<PAGE>
proceeding  including  without  limitation  one to enforce any judgment or award
resulting from any such  Proceeding.  Any such judgment or award shall contain a
specific  provision for the recovery of all such  subsequently  incurred  costs,
expenses, and actual attorneys' fees.

         14.15 Any  notice or other  communication  pursuant  to this  Agreement
shall be  sufficiently  made or given  five days  after the date  sent,  postage
pre-paid, by certified mail, return receipt requested,  if sent to the following
addresses, or to such other address as the Party may from time to time designate
to the other Parties in writing:
In the case of Bio-Products:

         Dr. Michael H. Eley, President & CEO
         BIO-PRODUCTS  INTERNATIONAL,  INC
         3317 Clifford  Road,  NW  Huntsville,
         Alabama  35810  USA
         256-852-3139   (phone)
         256-436-6992   (cellular)
         256-824-6305 (fax)
         eleym@email.uah.edu (email)

In the case of World Waste Technologies, Inc.:

         Thomas L. Collins, CEO
         WORLD WASTE TECHNOLOGIES, INC.
         13520 Evening Creek Dr., North
         Suite 130
         San Diego, CA 92128
         858-391-3400 (phone)
         858-204-0461 (cellular)
         858-486-3352 (fax)
         tcollins@worldwasteintl.com (email)

Each Party  shall make a  reasonable,  good faith  effort to ensure that it will
accept  or  receive  notices  to it that  are  given  in  accordance  with  this
paragraph.  A Party may change its address for  purposes  of this  paragraph  by
giving the other Parties written notice of a new address in the manner set forth
above.

         14.16 In the event  either  Party  hereto  shall be rendered  wholly or
partly  unable to perform  its  obligations  under this  Agreement  by reason of
causes beyond its control,  including but not limited to acts of Nature, acts of
terrorism,  acts, omissions,  or regulation of any government or agency thereof,
judicial action, labor disputes, or transportation  failure, except as specified
herein,  the  performance  of the  obligations  of such  Party  insofar as it is
affected  by  such  condition  shall  be  suspended  for  the  duration  of such
condition,  provided the Party affected  advises the other Party of the basis of
its  inability  within ten (10) days of the  beginning of such known  inability.
After the cessation of the condition causing such inability, the Party suffering
such  inability  shall  have a  period  of  thirty  (30)  days  to  restore  its
operation(s) and restore its obligations to the other Party.

         14.17 No  representations  have been made to any Party regarding taxes,
it being  understood  by each of the Parties  that each such Party  accepts full
responsibility  for  calculation  of and  payment of his or its  taxes,  levies,

                                Exhibit 10.6 - 20
<PAGE>
duties or other charges  incurred or imposed as a consequence  of this Agreement
and the transactions described herein.

         14.18 This Agreement  shall become  effective when it has been executed
by all of the Parties to this Agreement.

                                Exhibit 10.6 - 21
<PAGE>
         IN WITNESS  WHEREOF,  the  Parties  have caused  their duly  authorized
representatives  to duly execute and deliver this Agreement  effective as of the
date written above.

BIO-PRODUCTS INTERNATIONAL, INC.

By:  /s/ Dr. Michael H. Eley
   -----------------------------------------
        Dr. Michael H. Eley, President & CEO

WORLD WASTE TECHNOLOGIES, INC.

By:  /s/ Thomas L. Collins
    ----------------------------------------
        Thomas L. Collins, CEO

                                Exhibit 10.6 - 22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}]]